Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients.
Saved in:
| Title: | Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients. |
|---|---|
| Authors: | Munshani S; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA., Ibrahim EY; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA., Rodwin RL; Department of Pediatrics (Hematology/Oncology), Yale School of Medicine, New Haven, CT, USA., Ferrucci LM; Department of Chronic Disease Epidemiology and Yale Cancer Center, Yale School of Public Health, New Haven, CT, USA., Blenman K; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.; Department of Computer Science, School of Engineering and Applied Science, Yale University, New Haven, CT, USA., Lustberg M; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA., Ehrlich BE; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA. |
| Source: | FEBS open bio [FEBS Open Bio] 2026 Mar 26. Date of Electronic Publication: 2026 Mar 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101580716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-5463 (Electronic) Linking ISSN: 22115463 NLM ISO Abbreviation: FEBS Open Bio Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
